Atlas Trials

Sadat City University

25 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sadat City University

RecordFirmDate
Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection (NCT06546111)Sadat City University2024-10-01
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis (NCT06302049)Sadat City University2024-06-01
Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients (NCT04433988)Sadat City University2022-11-13
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer (NCT05433402)Sadat City University2022-07-20
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation (NCT05453916)Sadat City University2022-07-01
The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis (NCT04789837)Sadat City University2021-03-01
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis (NCT04767841)Sadat City University2021-02-16
Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease (NCT04761848)Sadat City University2021-02-16
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia (NCT04761861)Sadat City University2021-02-16
The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients (NCT04757571)Sadat City University2021-02-01
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT04751071)Sadat City University2021-02-01
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt (NCT05047146)Sadat City University2021-01-01
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients (NCT04410341)Sadat City University2020-05-01
Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients (NCT04434118)Sadat City University2020-03-20
The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT04344678)Sadat City University2020-01-01
The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder. (NCT04069819)Sadat City University2019-08-01
The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis (NCT04080947)Sadat City University2019-08-01
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients (NCT04068246)Sadat City University2019-08-01
Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus (NCT04075110)Sadat City University2019-07-01
Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia (NCT04094207)Sadat City University2019-01-01

Track Sadat City University automatically

Every clearance here is in the API, with alerts when new ones post.